421 related articles for article (PubMed ID: 10555913)
41. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
[TBL] [Abstract][Full Text] [Related]
42. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
43. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.
Khanna D; Aggarwal A; Bhakuni DS; Dayal R; Misra R
J Rheumatol; 2003 Jun; 30(6):1248-52. PubMed ID: 12784398
[TBL] [Abstract][Full Text] [Related]
44. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
45. [A case of microscopic polyarteritis nodosa associated with myeloperoxidase-antineutrophil cytoplasmic autoantibodies (MPO-ANCA)].
Arimura Y; Minoshima S; Kamiya Y; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):731-8. PubMed ID: 1362230
[TBL] [Abstract][Full Text] [Related]
46. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
[TBL] [Abstract][Full Text] [Related]
47. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine.
Choi HK; Slot MC; Pan G; Weissbach CA; Niles JL; Merkel PA
Arthritis Rheum; 2000 Nov; 43(11):2488-92. PubMed ID: 11083272
[TBL] [Abstract][Full Text] [Related]
49. Antineutrophil cytoplasm antibody: positivity and clinical correlation.
Martínez Téllez G; Torres Rives B; Rangel Velázquez S; Sánchez Rodríguez V; Ramos Ríos MA; Fuentes Smith LE
Reumatol Clin; 2015; 11(1):17-21. PubMed ID: 24913965
[TBL] [Abstract][Full Text] [Related]
50. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.
Schnabel A; Csernok E; Isenberg DA; Mrowka C; Gross WL
Arthritis Rheum; 1995 May; 38(5):633-7. PubMed ID: 7748219
[TBL] [Abstract][Full Text] [Related]
51. [Long-term development of children with Schönlein-Henoch purpura associated with anti-neutrophil cytoplasmic antibodies].
Blanco Quirós A; Conde Redondo F; Solis Sánchez P; Garrote Adrados JA; Gómez García S
An Esp Pediatr; 1999 Oct; 51(4):377-81. PubMed ID: 10690230
[TBL] [Abstract][Full Text] [Related]
52. [Renal microscopic polyarteritis replaced by pericarditis with episodic increases in MPO-ANCA in a patient with systemic lupus erythematosus].
Tomori K; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):597-601. PubMed ID: 9893459
[TBL] [Abstract][Full Text] [Related]
53. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
54. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis.
Cambridge G; Wallace H; Bernstein RM; Leaker B
Br J Rheumatol; 1994 Feb; 33(2):109-14. PubMed ID: 8162472
[TBL] [Abstract][Full Text] [Related]
55. [Clinical study on five myeloperoxidase specific anti-neutrophil cytoplasmic antibody (MPO-ANCA) positive Churg-Strauss syndrome cases].
Yoshihara K; Arimura Y; Kobayashi O; Minoshima S; Kobayashi M; Yomogita S; Soejima A; Nakabayashi K; Kitamoto K; Nagasawa T
Ryumachi; 1998 Oct; 38(5):696-704. PubMed ID: 9852746
[TBL] [Abstract][Full Text] [Related]
56. [Antineutrophil cytoplasmic antibodies and associated diseases].
Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
[TBL] [Abstract][Full Text] [Related]
57. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations.
Manolova I; Dancheva M; Halacheva K
Rheumatol Int; 2001 Jul; 20(5):197-204. PubMed ID: 11518040
[TBL] [Abstract][Full Text] [Related]
58. Atypical ANCA pattern with simultaneous presence of MPO and PR3-ANCA in systemic lupus erythematosus.
Chhabra S; Minz RW; Goyal L; Singh S
J Postgrad Med; 2010; 56(3):217-8. PubMed ID: 20739771
[No Abstract] [Full Text] [Related]
59. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Spronk PE; Bootsma H; Horst G; Huitema MG; Limburg PC; Tervaert JW; Kallenberg CG
Br J Rheumatol; 1996 Jul; 35(7):625-31. PubMed ID: 8670594
[TBL] [Abstract][Full Text] [Related]
60. Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases.
Chikazawa H; Nishiya K; Matsumori A; Hashimoto K
J Clin Immunol; 2000 Jul; 20(4):279-86. PubMed ID: 10939715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
